The NPI status was 1st published about 1992 as an attempt at using some fairly objective parameters to determine the odds that a newly diagnosed case of invasive ductal adenocarcinoma would benefit from adjuvant chemotherapy. By whatever means, the status of the axillary lymph nodes must be determined at least as to whether any nodes are positive for metastatic cancer (ALN+) or negative (ALN-). If any positive nodes, more details are needed. The studies looked at "overall survival" (OS) at 15 years post diagnosis. This grouping is just an initial categorization; many other patient-specific factors are taken together to make a final decision.
Decisions may have to be made prior to having the whole tumor out and size-measurable. By whatever measure, the following are the criteria for assignment of size points (such are finally, ultimately, assigned from the pathology tissue studies):
| maximum tumor size in centimeters:_____________times 0.2=________points. |
| from 1 (better) to 3 (worse), by whatever system, the tumor grade=___________points |
Use one of the following scoring methods:
| Classical scoring system:
| ||||||||||
| Alternative scoring system:
|
| Groups: | 80% OS @ 15 yrs if NPI <3.4 sum | 42% OS @ 15 yrs if NPI 3.4-5.4 sum | 13% OS @ 15 yrs if NPI >5.4 sum |
|---|---|---|---|
| Conclusions: as to need for adjuvant chemo. treatment | with chemo. |
***give me
your comments
about this page***
[Additionally see home page for website author & contact]
We comply with the
HONcode standard for trustworthy health information:
verify here.
(initially posted: 24 Dec. 2000)
check out the Highest TRUTH
check out this web site's site index
